Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01228214Phase 3Unknown
A Phase 3 trial of amiloride in coronary artery disease (CAD), sponsored by Universidad de Carabobo. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01228214.